19/04/23
Daniels G.O
The Director General Of The Nigerian Institute Of Medical Research Professor Babatunde Salako And other Health Experts have called on the Federal Government to look inward and develop effective indigenous solutions to tackle diseases of public health Concerns
Speaking During the evaluation Presentation of an herbal mixture ABUAD VIRUCIDINE which is said to have the potentials of being licensed for the treatment of COVID-19 ,The experts said even
though work on the medicine is still at a preliminary stage, findings show that it is very promising and that what needs to be done is to move on to the next stage which is to conduct study in larger number of people, after which the regulatory agency will be confident to register it as a treatment for COVID-19 in Nigeria pending the results of the full clinical trials.”
Out of 72 participants screened for the trials, 44 enrolled, and 43 (97.7 percent) of the enrolled participants completed the study.
A higher proportion of participants in the Virucidine trial were SARS-CoV-2 negative by day 3
All participants were SARS-CoV-2 negative by Day 14. A significantly higher proportion of participants on Virucidine were also symptom free by Day 7th Day.
Findings also showed that the Liquid was well tolerated and there were no serious adverse events, clinical deterioration or death through the 28 days of follow-up.”
ABUAD VIRUCIDINE is a project done in collaboration with Afe Babalola University of Ado Ekit, And The Nigerian Institute Of Medical Research NIMR,
Dara Network TV 